AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease
Authors: Andreassen, OA Dedeoglu, A Ferrante, RJ Jenkins, BG Ferrante, KL Thomas, M Friedlich, A Browne, SE Schilling, G Borchelt, DR Hersch, SM Ross, CA Beal, MF
Citation: Oa. Andreassen et al., Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease, NEUROBIOL D, 8(3), 2001, pp. 479-491
Lipoic acid improves survival in transgenic mouse models of Huntington's disease
Authors: Andreassen, OA Ferrante, RJ Dedeoglu, A Beal, MF
Citation: Oa. Andreassen et al., Lipoic acid improves survival in transgenic mouse models of Huntington's disease, NEUROREPORT, 12(15), 2001, pp. 3371-3373
Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis
Authors: Ferrante, RJ Klein, AM Dedeoglu, A Beal, MF
Citation: Rj. Ferrante et al., Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis, J MOL NEURO, 17(1), 2001, pp. 89-96
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease
Authors: Andreassen, OA Ferrante, RJ Huang, HM Dedeoglu, A Park, L Ferrante, KL Kwon, J Borchelt, DR Ross, CA Gibson, GE Beal, MF
Citation: Oa. Andreassen et al., Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease, ANN NEUROL, 50(1), 2001, pp. 112-117
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's diseasepathogenesis
Authors: Holbert, S Denghien, I Kiechle, T Rosenblatt, A Wellington, C Hayden, MR Margolis, RL Ross, CA Dausset, J Ferrante, RJ Neri, C
Citation: S. Holbert et al., The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's diseasepathogenesis, P NAS US, 98(4), 2001, pp. 1811-1816
Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid
Authors: Andreassen, OA Ferrante, RJ Klivenyi, P Klein, AM Dedeoglu, A Albers, DS Kowall, NW Beal, MF
Citation: Oa. Andreassen et al., Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid, EXP NEUROL, 168(2), 2001, pp. 356-363
Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP
Authors: Andreassen, OA Ferrante, RJ Dedeoglu, A Albers, DW Klivenyi, P Carlson, EJ Epstein, CJ Beal, MF
Citation: Oa. Andreassen et al., Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP, EXP NEUROL, 167(1), 2001, pp. 189-195
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
Authors: Chen, M Ona, VO Li, MW Ferrante, RJ Fink, KB Zhu, S Bian, J Guo, L Farrell, LA Hersch, SM Hobbs, W Vonsattel, JP Cha, JHJ Friedlander, RM
Citation: M. Chen et al., Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease, NAT MED, 6(7), 2000, pp. 797
Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity
Authors: Klivenyi, P Andreassen, OA Ferrante, RJ Lancelot, E Reif, D Beal, MF
Citation: P. Klivenyi et al., Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity, NEUROREPORT, 11(6), 2000, pp. 1265-1268
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
Authors: Kowall, NW Hantraye, P Brouillet, E Beal, MF McKee, AC Ferrante, RJ
Citation: Nw. Kowall et al., MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons, NEUROREPORT, 11(1), 2000, pp. 211-213
Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis
Authors: Andreassen, OA Ferrante, RJ Klivenyi, P Klein, AM Shinobu, LA Epstein, CJ Beal, MF
Citation: Oa. Andreassen et al., Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis, ANN NEUROL, 47(4), 2000, pp. 447-455
Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
Authors: Ferrante, RJ Andreassen, OA Jenkins, BG Dedeoglu, A Kuemmerle, S Kubilus, JK Kaddurah-Daouk, R Hersch, SM Beal, MF
Citation: Rj. Ferrante et al., Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease, J NEUROSC, 20(12), 2000, pp. 4389-4397
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
Authors: Klivenyi, P Andreassen, OA Ferrante, RJ Dedeoglu, A Mueller, G Lancelot, E Bogdanov, M Andersen, JK Jiang, DM Beal, MF
Citation: P. Klivenyi et al., Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, J NEUROSC, 20(1), 2000, pp. 1-7
Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenicmice expressing a caspase-1 dominant-negative mutant
Authors: Andreassen, OA Ferrante, RJ Hughes, DB Klivenyi, P Dedeoglu, A Ona, VO Friedlander, RM Beal, MF
Citation: Oa. Andreassen et al., Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenicmice expressing a caspase-1 dominant-negative mutant, J NEUROCHEM, 75(2), 2000, pp. 847-852
Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice
Authors: Jenkins, BG Klivenyi, P Kustermann, E Andreassen, OA Ferrante, RJ Rosen, BR Beal, MF
Citation: Bg. Jenkins et al., Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice, J NEUROCHEM, 74(5), 2000, pp. 2108-2119
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Authors: Klivenyi, P Ferrante, RJ Matthews, RT Bogdanov, MB Klein, AM Andreassen, OA Mueller, G Wermer, M Kaddurah-Daouk, R Beal, MF
Citation: P. Klivenyi et al., Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis, NAT MED, 5(3), 1999, pp. 347-350
Oxidative stress in Huntington's disease
Authors: Browne, SE Ferrante, RJ Beal, MF
Citation: Se. Browne et al., Oxidative stress in Huntington's disease, BRAIN PATH, 9(1), 1999, pp. 147-163
Transgenic mice expressing a dominant negative mutant interleukin-1 beta converting enzyme show resistance to MPTP neurotoxicity
Authors: Klevenyi, P Andreassen, O Ferrante, RJ Schleicher, JR Friedlander, RM Beal, MF
Citation: P. Klevenyi et al., Transgenic mice expressing a dominant negative mutant interleukin-1 beta converting enzyme show resistance to MPTP neurotoxicity, NEUROREPORT, 10(3), 1999, pp. 635-638
Huntingtin aggregates may not predict neuronal death in Huntington's disease
Authors: Kuemmerle, S Gutekunst, CA Klein, AM Li, XJ Li, SH Beal, MF Hersch, SM Ferrante, RJ
Citation: S. Kuemmerle et al., Huntingtin aggregates may not predict neuronal death in Huntington's disease, ANN NEUROL, 46(6), 1999, pp. 842-849
Oxidative stress is attenuated in mice overexpressing BCL-2
Authors: Bogdanov, MB Ferrante, RJ Mueller, G Ramos, LE Martinou, JC Beal, MF
Citation: Mb. Bogdanov et al., Oxidative stress is attenuated in mice overexpressing BCL-2, NEUROSCI L, 262(1), 1999, pp. 33-36
Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
Authors: Gutekunst, CA Li, SH Yi, H Mulroy, JS Kuemmerle, S Jones, R Rye, D Ferrante, RJ Hersch, SM Li, XJ
Citation: Ca. Gutekunst et al., Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology, J NEUROSC, 19(7), 1999, pp. 2522-2534
Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage
Authors: Eliasson, MJL Huang, ZH Ferrante, RJ Sasamata, M Molliver, ME Snyder, SH Moskowitz, MA
Citation: Mjl. Eliasson et al., Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage, J NEUROSC, 19(14), 1999, pp. 5910-5918
Near-infrared fluorescence spectroscopy detects Alzheimer's disease in vitro
Authors: Hanlon, EB Itzkan, I Dasari, RR Feld, MS Ferrante, RJ McKee, AC Lathi, D Kowall, NW
Citation: Eb. Hanlon et al., Near-infrared fluorescence spectroscopy detects Alzheimer's disease in vitro, PHOTOCHEM P, 70(2), 1999, pp. 236-242
Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy
Authors: Shefner, JM Reaume, AG Flood, DG Scott, RW Kowall, NW Ferrante, RJ Siwek, DF Upton-Rice, M Brown, RH
Citation: Jm. Shefner et al., Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy, NEUROLOGY, 53(6), 1999, pp. 1239-1246
Tissue transglutaminase is increased in Huntington's disease brain
Authors: Lesort, M Chun, WJ Johnson, GVW Ferrante, RJ
Citation: M. Lesort et al., Tissue transglutaminase is increased in Huntington's disease brain, J NEUROCHEM, 73(5), 1999, pp. 2018-2027
Risultati: 1-25 | 26-28